Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Credit Suisse Adjusts Johnson & Johnson's Price Target to $193 from $168, Keeps Outperform Rating

01/27/2021 | 09:24am EDT


ę MT Newswires 2021
All news about JOHNSON & JOHNSON
08/04JOHNSON & JOHNSON : FDA - Coronavirus Update
AQ
08/04JOHNSON & JOHNSON : U.S. Govt Donates 151,200 Doses of J&J Vaccines to MoH
AQ
08/04JOHNSON & JOHNSON : 11,000 Tunisian Students Studying Abroad to Receive Covid-19..
AQ
08/03ZYMEWORKS : Says Earned Milestone Payment From Johnson & Johnson Under Licensing..
MT
08/03Johnson & Johnson Appoints Sandipan Ghatak as Head of Consumer Health India C..
CI
08/03CORONAVIRUS : AVAT to partner with UNICEF in scaling up vaccine deliveries to Af..
AQ
08/03CORONAVIRUS : AVAT to partner with UNICEF in scaling up vaccine deliveries to Af..
AQ
08/03JOHNSON & JOHNSON : Eyes Ways To Fast-Track COVID-19 Vaccine Delivery To India
MT
08/02JOHNSON & JOHNSON : Janssen Pharmaceutical - UPTRAVI Receives FDA Approval for I..
AQ
08/02MARKET CHATTER : Johnson & Johnson Reportedly in Ongoing Talks With India on COV..
MT
More news
Financials (USD)
Sales 2021 94 457 M - -
Net income 2021 22 808 M - -
Net Debt 2021 853 M - -
P/E ratio 2021 20,3x
Yield 2021 2,40%
Capitalization 456 B 456 B -
EV / Sales 2021 4,84x
EV / Sales 2022 4,62x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 173,36 $
Average target price 184,35 $
Spread / Average Target 6,34%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON10.15%456 367
ROCHE HOLDING AG14.16%340 492
PFIZER, INC.22.77%255 703
ELI LILLY AND COMPANY55.45%232 701
NOVARTIS AG-0.20%224 638
NOVO NORDISK A/S36.67%213 138